Somatropin 191 is a recombinant form of human growth hormone (HGH) that is used in the management of specific growth hormone deficiencies and other approved endocrine conditions. It is structurally comparable to naturally occurring human growth hormone and works by supporting growth and regulating various physiological processes.

Somatropin treatment is prescribed according to the patient’s diagnosis, age, clinical condition, and response to therapy. Because growth hormone can affect multiple body systems, treatment requires appropriate medical assessment and regular monitoring by a qualified healthcare professional.

Key Information

Contains somatropin (recombinant human growth hormone)

Prescription biological medicine

Used for approved growth hormone-related conditions

Administered by injection

Requires individualized dosing and medical monitoring

Active Ingredient

Somatropin

Strength

191

Dosage Form

Injectable preparation

Indications

Somatropin may be prescribed for confirmed growth hormone deficiency and other approved endocrine or growth-related disorders, depending on the patient’s medical condition and applicable prescribing guidelines.

Storage

Store according to the manufacturer’s instructions. Refrigerated storage may be required depending on the specific formulation. Protect the product from freezing, excessive heat, and direct sunlight, and keep it out of reach of children.